Corebridge Financial, Inc. (CRBG)
(Delayed Data from NYSE)
$29.75 USD
+0.02 (0.07%)
Updated Jul 30, 2024 04:00 PM ET
After-Market: $29.72 -0.03 (-0.10%) 7:58 PM ET
4-Sell of 5 4
A Value D Growth C Momentum C VGM
Corebridge Financial (CRBG) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$33.46 | $40.00 | $24.00 | 12.55% |
Price Target
Based on short-term price targets offered by 13 analysts, the average price target for Corebridge Financial comes to $33.46. The forecasts range from a low of $24.00 to a high of $40.00. The average price target represents an increase of 12.55% from the last closing price of $29.73.
Analyst Price Targets (13)
Broker Rating
Corebridge Financial currently has an average brokerage recommendation (ABR) of 1.71 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 14 brokerage firms. The current ABR compares to an ABR of 1.71 a month ago based on 14 recommendations.
Of the 14 recommendations deriving the current ABR, eight are Strong Buy and two are Buy. Strong Buy and Buy respectively account for 57.14% and 14.29% of all recommendations. A month ago, Strong Buy made up 57.14%, while Buy represented 14.29%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 8 | 8 | 8 | 8 | 8 |
Buy | 2 | 2 | 2 | 2 | 2 |
Hold | 4 | 4 | 4 | 4 | 4 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.71 | 1.71 | 1.71 | 1.71 | 1.71 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
6/28/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
6/11/2024 | Not Identified | Not Identified | Hold | Hold |
4/12/2024 | Not Identified | Not Identified | Moderate Buy | Moderate Buy |
4/11/2024 | Wells Fargo Securities | Elyse Greenspan | Strong Buy | Strong Buy |
4/11/2024 | Evercore Partners | Thomas Gallagher | Strong Buy | Strong Buy |
4/10/2024 | Keefe Bruyette & Woods | Ryan Krueger | Moderate Buy | Moderate Buy |
4/5/2024 | Piper Sandler | John Barnidge | Strong Buy | Strong Buy |
1/10/2024 | UBS | Brian R Meredith | Strong Buy | Strong Buy |
1/9/2024 | Goldman Sachs | Alex Scott | Strong Buy | Strong Buy |
1/9/2024 | Dowling & Partners | Joel Hurwitz | Not Available | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.71 |
ABR (Last week) | 1.71 |
# of Recs in ABR | 14 |
Average Target Price | $33.46 |
LT Growth Rate | 15.70% |
Industry | Insurance - Multi line |
Industry Rank by ABR | 99 of 252 |
Current Quarter EPS Est: | 1.10 |